Skip to the answer
Gyna

Preparing for IVF

Which supplements are safe before and during IVF medication?

The short answer

Your in vitro fertilization (IVF) team needs to check your actual products and medicines.

  • Already following a prescribed plan? Ask before changing it.
  • Considering coenzyme Q10 (CoQ10), herbs or a fertility blend? Get clinic review before adding it.
  • Egg retrieval or embryo transfer approaching? Ask for product-specific instructions, not an online stop date.

Don't stop prescribed medicines or delay IVF for supplements. Promising pregnancy results don't establish safety with your medication.

Evidence limits shown Sources are linked. Not yet reviewed by a clinician.

How we check answers

What can I do with this?

Start with the products you already have, rather than a longer shopping list. Bring their packaging or clear label photos to your clinic or pharmacist. Include your prenatal, individual vitamins, powders, herbs and fertility blends, alongside prescription and nonprescription medicines. The ingredient amounts matter as well as the names. Combining products or taking too much can create problems that a single-product discussion misses.

The FDA says a Supplement Facts label should show the serving size, dietary ingredients and their amounts per serving. Have that panel available, not just the name on the front of the bottle. Tell your team how much you actually take and why you started it. That gives them something specific to review without asking you to decide which ingredients are safe yourself.

A useful question is: “Can you check this whole list against my treatment plan?” Then ask which products have a clear purpose for you, whether ingredients overlap, and whether instructions change before retrieval, transfer or a pregnancy test. Those are questions for the team managing your care. This page doesn't provide a stopping calendar, and another patient's clinic instructions aren't your own.

If your clinician has prescribed something for a specific reason, bring that reason into the conversation too. Don't replace a prescribed medicine with a supplement or stop it because a general article sounds worrying. ACOG explicitly advises discussing prescription changes first. If you're considering an optional add-on, ask what outcome the evidence supports: a laboratory measure, clinical pregnancy, live birth or correction of a nutritional need. You deserve an answer that names the difference.

But does this apply to me?

This answer is for people preparing for or taking IVF medication who want to check supplements safely. The CoQ10 trial in younger women with poor reserve doesn't automatically describe someone over 40, someone with a different diagnosis or every donor cycle.

The review findings also don't establish safety after transfer or during pregnancy. General prenatal guidance is relevant to pregnancy planning, but your clinic still needs your health history and treatment details to apply it.

Care and safety

When should I bring in a clinician?

“No increase in harm was detected” isn't the same as “safe with my medication.” Poorly reported side effects leave a gap; they don't fill it. We haven't established a safe list for DHEA, herbs, melatonin or other add-ons, or a universal number of days to stop anything before a procedure. A product missing from this page has not been cleared or ruled out.

If you suspect a reaction to a supplement, seek medical advice promptly and tell the team what you took. Don't wait for an article to identify the cause. For routine decisions, the useful next step is a clinic-reviewed list with clear instructions. There's no need to turn uncertain research into another preparation target you have to meet before you're allowed to proceed with care.

Understand the answer

So what does this mean for me?

What does the research actually say?

“But isn't CoQ10 supposed to help?” There is research worth discussing, especially for people with reduced ovarian reserve. In a 2018 randomized trial, 186 women under 35 with poor ovarian reserve were assigned to CoQ10 before IVF or no pretreatment. The researchers evaluated 169 women after excluding 17 for low adherence. They found improvements in ovarian response and embryo measures, but no statistically clear improvement in clinical pregnancy (a clinically confirmed pregnancy) or live birth. That is encouraging research, with an important limit.

The pretreatment lasted 60 days. That's how this particular trial was designed, not evidence that you need to postpone a cycle for two months. Its main outcome was high-quality embryos, and its participants were a specific group of younger women. Neither detail can quietly disappear when the study becomes advice for someone else.

A 2020 review pooled five randomized trials involving 449 women having assisted reproduction. Clinical pregnancy was reported in 28.8% of the CoQ10 group and 14.1% of the comparison group. But the live-birth result remained uncertain: its confidence interval included both lower and higher odds. The review also found no statistically clear difference in miscarriage. More pregnancies in these trials didn't establish that more people took home a baby.

A 2024 review of six trials and 1,529 participants with diminished ovarian reserve also found a favorable clinical-pregnancy result. The authors cautioned that study methods were poorly described. The abstract doesn't give a live-birth estimate. We read these papers as abstracts, so we can't use them to check every adverse event, medication combination or treatment-stage detail. Taken together, they support a conversation with your clinic, not a safety stamp for your supplement cupboard.

How does this compare with the official guidance?

Cochrane looked more broadly at antioxidants used by women with fertility problems. Its 2020 review included 63 trials and 7,760 women, but only 13 trials contributed to the live-birth analysis. The authors were uncertain about live-birth benefit because that evidence was very low quality. Adverse effects were poorly reported. The review covered different supplements and comparisons; it wasn't a trial of taking them all together.

The FDA addresses a different question: what can go wrong when you take a supplement? Some ingredients can interact with medicines, affect laboratory tests or cause problems during surgery. “Natural” doesn't guarantee safety, and dietary supplements aren't approved by the FDA for safety and effectiveness before sale. Those warnings don't tell us which product is unsuitable for your cycle. They explain why your actual medicines and labels need checking.

ACOG recommends a prenatal vitamin with folic acid before pregnancy and a review of medicines, vitamins and herbs. That's pregnancy-health guidance, not a recommendation for every fertility supplement. The promising CoQ10 findings can sit alongside that guidance without becoming a universal prescription. One question is whether something might help a selected treatment group; another is whether you should take it with your current medicines.

Why is this our answer?

We read three research abstracts, the Cochrane public summary and review abstract, and FDA and ACOG guidance. Some findings are encouraging, but safety reporting and live-birth evidence are limited.

Sources for each main claim

What else are you wondering?

Explore all preparing for ivf questions

Check the evidence

How sure can I be?

See the full evidence snapshot and sources

Evidence snapshot

The same fields appear on every Gyna answer, including when the research did not report something reliably.

Question and decision
Which supplements are safe before and during IVF medication? Whether to combine products with medication requires clinic review, not a generic supplement list.
Who was studied
Women in assisted reproduction, including selected diminished-reserve groups. The 2018 trial enrolled women under 35 with poor reserve; not all IVF patients.
What was compared
CoQ10 pretreatment versus none or placebo in trials; mixed antioxidants in Cochrane. A trial used 60 days, not a required waiting period. No dose or stop protocol offered.
Outcome measured, and over what period
Ovarian response and embryo measures during treatment, clinical pregnancy, live birth and miscarriage where reported. No standardized medication-interaction outcome or individual time-to-benefit is established here.
Kinds of evidence included
Three tier-C abstracts (one randomized trial, two meta-analyses); tier-B Cochrane public summary and abstract, FDA supplement information, and ACOG prepregnancy FAQ.
Studies and participants
2018: 186 randomized, 169 evaluated. 2020 CoQ10 review: 5 trials/449 women. 2024: 6 trials/1,529 participants. Cochrane antioxidants: 63 trials/7,760 women overall; live birth 13 trials/1,227 women. Possible overlap; do not sum totals.
What the evidence shows
An odds ratio (OR) compares group odds, not absolute chances. 2020 CoQ10 clinical pregnancy: 28.8% versus 14.1%, OR 2.44 (95% CI 1.30–4.59). Live birth: OR 1.67 (0.66–4.25), not a statistically clear difference. 2024 clinical pregnancy: OR 1.84 (1.33–2.53); no live-birth estimate in abstract. These results do not quantify individual benefit or establish combination safety.
Consistency and disagreement
Clinical-pregnancy findings are encouraging in selected groups, but the 2018 trial and 2020 synthesis do not establish live-birth benefit. The 2024 authors flag poorly described methods; Cochrane grades broader live-birth evidence very low. Different products, populations and outcomes prevent a single efficacy verdict.
Confidence in this answer
Limited for selected CoQ10 clinical-pregnancy benefit; insufficient for a general live-birth promise or individualized supplement-drug safety. General safety-review advice is authoritative, not proof of any specific combination's safety.
Strength of the sources
Randomized research summarized at abstract depth; broader Cochrane review summary and abstract; full FDA and ACOG general guidance. No IVF interaction protocol read.
Review status
Sources are linked. Not yet reviewed by a clinician.
Who this does and does not describe
Clinic conversation before/during IVF; not clearance for older, donor, male-partner or post-transfer populations. Health history, ingredients and medicines matter.
Harms, trade-offs and when to seek care
Drug, test and surgery interactions are possible; adverse-event reporting is weak. Clinic controls additions and stop/restart instructions. Do not change prescriptions or delay IVF for supplements. Seek prompt medical advice for a suspected reaction.
Last searched, and the records behind this
Last evidence search 2026-09-07. The source links are listed below.

Sources

Open the original guidance or study rather than taking our summary on trust.

  1. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.

    pubmed.ncbi.nlm.nih.gov · 2018

  2. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials

    J Assist Reprod Genet · 2020

  3. Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis

    Ann Med · 2024

  4. Antioxidants for female subfertility (PLS: Vitamins and minerals for subfertility in women)

    Cochrane · 27 August 2020 (CD007807.pub4)

  5. FDA
  6. Good Health Before Pregnancy: Prepregnancy Care (FAQ)

    ACOG · Last reviewed October 2025

How we looked, and what we found

We searched our research library and read the sources on September 7, 2026. The three research papers were read as complete abstracts; Cochrane's page supplied its public summary and review abstract.

We didn't inspect full trial safety tables or search the open web. Reviews may include some of the same trials, so their participant totals mustn't be added together.

The missing detail most likely to change a personal decision is product-and-medication-specific safety information, which this article cannot supply.

Who wrote this, and when will we revisit it?

Prepared by Gyna from our research library. The source map below shows which findings support each conclusion.

Last updated
2026-09-08

Tell us something here is wrong